VPHIF (Valeo Pharma) Total Assets: $23.48 Mil (As of Jul. 2024)


VPHIF Valeo Pharma Inc VPHIF
12 GF Score
Price $0.00
View Full Analysis

What is Valeo Pharma Total Assets?

Valeo Pharma VPHIF -99.00% 12 Total Assets is $23.48 Mil as of Jul. 2024. GuruFocus rates VPHIF with a GF Score™ of 12/100.

Valeo Pharma's Total Assets for the quarter that ended in Jul. 2024 was $23.48 Mil.

Total Assets is connected with ROA %. Valeo Pharma's annualized ROA % for the quarter that ended in Jul. 2024 was -98.00%. Total Assets is also linked to Revenue through Asset Turnover. Valeo Pharma's Asset Turnover for the quarter that ended in Jul. 2024 was 0.38.

Valeo Pharma  (OTCPK:VPHIF) Total Assets Explanation

Total Assets is connected with ROA %.

Valeo Pharma's annualized ROA % for the quarter that ended in Jul. 2024 is

ROA %=Net Income (Q: Jul. 2024 )/( (Total Assets (Q: Apr. 2024 )+Total Assets (Q: Jul. 2024 ))/ count )
=-23.892/( (25.284+23.476)/ 2 )
=-23.892/24.38
=-98.00 %

Note: The Net Income data used here is four times the quarterly (Jul. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Valeo Pharma's Asset Turnover for the quarter that ended in Jul. 2024 is

Asset Turnover
=Revenue (Q: Jul. 2024 )/( (Total Assets (Q: Apr. 2024 )+Total Assets (Q: Jul. 2024 ))/ count )
=9.188/( (25.284+23.476)/ 2 )
=9.188/24.38
=0.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Valeo Pharma Total Assets Related Terms

Valeo Pharma Total Assets Historical Data

* Premium members only.

The historical data trend for Valeo Pharma's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Valeo Pharma Total Assets Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Total Assets
Get a 7-Day Free Trial 4.40 8.29 16.91 42.56 30.05

Valeo Pharma Quarterly Data
Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.47 30.05 30.06 25.28 23.48
VPHIF
12GF Score
Valeo Pharma Inc VPHIF
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Valeo Pharma Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Valeo Pharma's Total Assets for the fiscal year that ended in Oct. 2023 is calculated as

Total Assets=Total Equity (A: Oct. 2023 )+Total Liabilities (A: Oct. 2023 )
=-29.417+59.469
=30.05

Valeo Pharma's Total Assets for the quarter that ended in Jul. 2024 is calculated as

Total Assets=Total Equity (Q: Jul. 2024 )+Total Liabilities (Q: Jul. 2024 )
=-45.963+69.439
=23.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of $23.48 Mil mean?
Valeo Pharma (VPHIF) has a Total Assets of $23.48 Mil as of Jul. 2024. The total amount of assets as recorded on a company's balance sheet. View historical data on Valeo Pharma and its competitors.
Is Valeo Pharma's Total Assets too high?
Valeo Pharma's current Total Assets is $23.48 Mil. Overall, Valeo Pharma has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Valeo Pharma's Total Assets compare to ZTS?
Valeo Pharma's Total Assets of $23.48 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Drug Manufacturers company?
A good Total Assets depends on the Drug Manufacturers industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Valeo Pharma and its competitors. Valeo Pharma's current Total Assets is $23.48 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valeo Pharma stock overvalued right now?
Valeo Pharma (VPHIF) has a current Total Assets of $23.48 Mil. The current Total Assets is $23.48 Mil. Valeo Pharma's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Valeo Pharma (VPHIF), the current Total Assets is $23.48 Mil as of Jul. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Valeo Pharma Business Description

Address 16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and hospital specialty products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.
12GF Score

Get the complete analysis for VPHIF

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price